In girls and women aged 9 through 45, GARDASIL^®9 helps protect against cervical, vaginal, vulvar and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58, abnormal and precancerous cervical lesions as found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, abnormal and precancerous vaginal, vulvar and anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, and genital warts caused by HPV types 6 and 11. In boys and men aged 9 through 45, GARDASIL^®9 helps protect against anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58, and abnormal and precancerous anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. It also helps protect boys and men aged 9 through 45 against genital warts caused by HPV types 6 and 11.

GARDASIL^®9 does not treat HPV infection, cancer or prevent its complications. GARDASIL^®9 may not fully protect each person who gets it. GARDASIL^®9 does not remove the need for cervical cancer screening; women should still get routine cervical cancer screening. GARDASIL^®9 is not recommended for use in pregnant women. As with other vaccines, GARDASIL^®9 may cause some side effects and allergic reactions. The most common side effects seen are pain, swelling, redness, itching, bruising, bleeding, a lump where the shot is given, headache, fever, nausea, dizziness, tiredness, diarrhea, abdominal pain and sore throat. This is not a complete list of side effects; for any unexpected effects while
taking GARDASIL^®9, contact your doctor or pharmacist. Contact your doctor or healthcare professional to if GARDASIL^®9 is suitable for you.

Information about GARDASIL^®9 is provided in the Product Monograph and Consumer Information, available here.

HPV=human papillomavirus.